Cite
HARVARD Citation
Czarnecka, A. et al. (2015). Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience. Future oncology. pp. 2267-2282. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Czarnecka, A. et al. (2015). Feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience. Future oncology. pp. 2267-2282. [Online].